Connect with us

Hi, what are you looking for?

Investing

ChemX Receives $661,890 R&D Refund

ChemX Materials Limited (ASX:CMX) (ChemX or the Company), an Australian high purity critical materials company and 100%-owner of the HiPurA® patented process to produce High Purity Alumina (HPA) in O’Connor, Western Australia is pleased to advise it has received its FY24 R&D Refund from the ATO.

ChemX Receives $661,890 R&D Refund Radium Capital Facility Repaid

As announced to ASX on 6th September 2024, the Company obtained an advance against its expected R&D Return. The refund received extinguishes the facility taken out with Radium Capital for $442,000. After repayment of fees and charges for the facility the Company has received a surplus of $207,381. The surplus will be used towards working capital for the Company.

Click here for the full ASX Release

This article includes content from ChemX Materials, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

This post appeared first on investingnews.com

You May Also Like

Latest News

In what could potentially be President Biden’s last foreign diplomacy trip, he will soon head to South America to meet with global leaders, including...

Latest News

Ranked choice voting suffered a blow as several states, including Nevada, Oregon, Colorado and Idaho rejected measures last week. In Colorado, Proposition 131 would...

Investing

Cobalt market watchers are warning that a near-term resurgence in prices and demand may not occur. Cobalt prices have spent most of 2024 on...

Latest News

House Speaker Mike Johnson, R-La., won unanimous approval from Republican lawmakers earlier this week to lead the House of Representatives next year, but some...

Disclaimer: Earlyagenda.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Earlyagenda.com